Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Tissue culture for non-neoplastic disorders; amniotic fluid or chorionic villus cells

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

A tissue culture for non-neoplastic disorders, as described by CPT® Code 88235, involves the cultivation of amniotic fluid or chorionic villus cells. This procedure is essential for conducting a chromosome analysis that is separately reportable and specifically targets non-neoplastic disorders. Non-neoplastic disorders encompass a range of genetic conditions that do not involve tumors but can lead to significant congenital anomalies or other health issues. Examples of these disorders include sister chromatid exchange (SCE), breakage syndromes, trisomies, and mosaicism. The process begins with the collection of amniotic fluid or chorionic villus samples, which are critical for obtaining the necessary cells for analysis. The amniotic fluid is collected using specialized syringes and placed in secure screw-top tubes to maintain the integrity of the sample. Alternatively, chorionic villus sampling (CVS) may be performed, where care is taken to remove any blood clots under sterile conditions before placing the specimen in the appropriate containers. Once collected, these samples are transported to a laboratory in a culture medium, where the cells are cultured to facilitate genetic testing and chromosome analysis. This procedure is vital for diagnosing genetic conditions and guiding patient management.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure described by CPT® Code 88235 is indicated for the evaluation of non-neoplastic disorders, which may include the following conditions:

  • Sister Chromatid Exchange (SCE) - A genetic phenomenon where sister chromatids exchange genetic material, which can be indicative of certain genetic disorders.
  • Breakage Syndromes - A group of genetic disorders characterized by an increased susceptibility to chromosome breakage, leading to various health issues.
  • Trisomies - Conditions resulting from the presence of an extra chromosome, such as Down syndrome (trisomy 21), which can lead to developmental and physical challenges.
  • Mosaicism - A condition where an individual has two or more genetically different cell lines, which can result in a range of phenotypic expressions and health implications.
  • Other Genetic Conditions - Various congenital anomalies and genetic disorders that may not fall into the above categories but require chromosome analysis for diagnosis and management.

2. Procedure

The procedure for CPT® Code 88235 involves several critical steps to ensure the successful culture of amniotic fluid or chorionic villus cells:

  • Step 1: Sample Collection - The first step involves performing an amniocentesis or chorionic villus sampling (CVS) to collect the necessary specimens. For amniocentesis, a needle is carefully inserted into the amniotic sac to withdraw amniotic fluid, which contains fetal cells. In the case of CVS, a small sample of placental tissue is obtained, and care is taken to avoid contamination with maternal blood.
  • Step 2: Specimen Preparation - Once the samples are collected, they are placed in sterile screw-top tubes to prevent contamination and maintain the viability of the cells. If a CVS specimen is obtained, any blood clots are meticulously removed using sterile gloves and a stereomicroscope before placing the specimen in the culture medium.
  • Step 3: Transport to Laboratory - The prepared amniotic fluid or CVS specimens are then transported to the laboratory in a suitable culture medium. This medium is essential for supporting the growth and division of the cells during the culture process.
  • Step 4: Cell Culture - In the laboratory, the cells from the amniotic fluid or chorionic villus are cultured under controlled conditions to promote cell growth. This process may involve the addition of specific stains or chemicals, depending on the type of chromosome analysis being performed.

3. Post-Procedure

After the procedure, the cultured cells are monitored for growth and division, which is necessary for subsequent chromosome analysis. The laboratory will prepare the cells for analysis, which may include staining and preparing slides for microscopic examination. The results of the chromosome analysis will provide critical information regarding the presence of any genetic abnormalities or conditions. It is important for healthcare providers to communicate the results to the patient and discuss any further steps or interventions that may be necessary based on the findings.

Short Descr TISSUE CULTURE PLACENTA
Medium Descr TISS CUL NON-NEO DISORDERS AMNIOTIC/CHORNC CELLS
Long Descr Tissue culture for non-neoplastic disorders; amniotic fluid or chorionic villus cells
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"